Medical Device Registration Cost by Country: 2026 Global Comparison
Compare medical device registration costs, government fees, project budgets, and timelines across the US, EU, Brazil, Japan, Korea, India, China, Saudi Arabia, UK, and more.
Why Compare Registration Costs Across Countries
Expanding a medical device into international markets is one of the most consequential strategic decisions a manufacturer can make -- and one of the most expensive. A single miscalculation in regulatory budgeting can delay market entry by months or consume margins that took years to build.
Yet most companies still plan country-by-country, relying on fragmented intelligence from consultants, trade associations, or outdated blog posts. Government fees are published publicly, but they tell only a fraction of the story. The total cost of registration includes consulting fees, local representative retainers, document translation, product testing, clinical evidence preparation, and ongoing compliance obligations. Two countries with similar government fees can have total project costs that differ by a factor of five.
This guide provides the first truly comprehensive side-by-side comparison of medical device registration costs across 30+ markets. Every fee figure is sourced from the official fee schedules published by each regulatory authority, supplemented by total cost estimates from regulatory consultancies operating in each market. All dollar amounts are in USD unless otherwise noted. Exchange rates are approximate as of early 2026.
Whether you are a startup planning your first international filing or an established manufacturer optimizing a global registration portfolio, the data below will help you build accurate budgets, prioritize the right markets, and avoid costly surprises.
Quick Comparison Table: Government Fees and Total Costs
The table below summarizes government fees, estimated total project costs, timelines, and registration validity across major markets. "Estimated Total Cost" includes government fees plus typical consulting, local representation, translation, and testing costs for a single Class II equivalent device.
| Country | Authority | Device Class | Government Fees | Estimated Total Cost | Timeline | Validity |
|---|---|---|---|---|---|---|
| United States | FDA | 510(k) Class II | $26,067 (std) / $6,517 (SB) | $50,000--$150,000 | 6+ months | No expiration |
| United States | FDA | PMA Class III | $579,272 (std) / $144,818 (SB) | $500,000--$2M+ | 12--18+ months | No expiration |
| United States | FDA | Annual Registration | $11,423 | $11,423/year | Annual | Annual renewal |
| EU | Notified Body | Class I (self-cert) | EUR 750--2,500 | $2,000--$5,000 | 4--6 weeks | Up to 5 years |
| EU | Notified Body | Class II/III | EUR 3,000--15,000+ | $8,000--$50,000+ | 6--18 months | Up to 5 years |
| UK | MHRA | All classes | GBP 300/category/year (from April 2026) | $5,000--$15,000 | 3--6 months | Annual renewal |
| Brazil | ANVISA | Class I/II (notification) | BRL 1,406 (~$265) | $3,800--$10,000 | 30 days | 10 years |
| Brazil | ANVISA | Class III/IV (registration) | BRL 8,510--19,856 (~$1,606--$3,747) | $35,000--$142,000 | 12--24 months | 10 years |
| Japan | PMDA | Class I (Todokede) | Minimal | $5,000--$20,000 | Less than 1 month | No expiration |
| Japan | PMDA | Class II (Ninsho) | ~$30,000 avg | $30,000--$80,000 | 3--6 months | 5-year QMS renewal |
| Japan | PMDA | Class III/IV (Shonin) | $20,000--$120,000 | $50,000--$200,000+ | 6--36 months | No expiration |
| South Korea | MFDS | Class I | KRW 85,000 (~$73) | $5,000--$15,000 | Less than 1 month | No expiration |
| South Korea | MFDS | Class II | KRW 719,000--1,495,000 (~$617--$1,283) | $20,000--$50,000 | 4--10 months | No expiration |
| South Korea | MFDS | Class III/IV | KRW 719,000--1,495,000 (~$617--$1,283) | $30,000--$60,000 | 6--10 months | No expiration |
| China | NMPA | Class II (imported) | RMB 210,900 (~$30,000) | $30,000--$80,000 | 12--24 months | 5 years |
| China | NMPA | Class III (imported) | RMB 308,800 (~$44,000) | $50,000--$150,000 | 12--36 months | 5 years |
| India | CDSCO | Class A--D | $1,000--$3,000/site | $10,000--$30,000 | 5--12 months | Perpetual (no expiry) |
| Saudi Arabia | SFDA | Class A--D | SAR 15,000--23,000 (~$4,000--$6,133) | $15,000--$30,000 | 35 work days | 3 years |
| Australia | TGA | Class I | AUD 621 (~$416) | $3,000--$8,000 | 1--5 days | Perpetual |
| Australia | TGA | Class II/III/IV | AUD 1,187--1,530 + audit fees | $10,000--$50,000 | 6--12 months | Perpetual |
| Canada | Health Canada | Class II--IV | CAD 632--30,199 | $10,000--$40,000 | 15 days--15 months | No expiration |
| Singapore | HSA | Class B | S$1,560--4,460 (~$1,170--$3,350) | $5,000--$15,000 | Immediate--160 days | Perpetual |
| Singapore | HSA | Class C | S$3,900--6,810 (~$2,930--$5,110) | $8,000--$25,000 | Immediate--220 days | Perpetual |
| Singapore | HSA | Class D | S$6,490--12,560 (~$4,870--$9,430) | $15,000--$40,000 | 180--310 days | Perpetual |
| Mexico | COFEPRIS | Low Risk | MXN 15,206 (~$800) | $1,000--$2,000 | 1--3 months | 5 years (now 10 per Jan 2026 decree) |
| Mexico | COFEPRIS | Class II/III | MXN 22,302--28,394 (~$1,100--$1,500) | $5,000--$7,000 | 3--10 months | 5 years (now 10) |
| Colombia | INVIMA | Class IIb/III (controlled) | ~$700--$1,000 | $10,000--$25,000 | 6--8 months | 10 years |
| Vietnam | MoH | Class A--D | VND 500K--6M (~$21--$260) | $6,000--$35,000 | 3--60 days | Indefinite (Decree 98) |
Sources: FDA.gov Federal Register FY2026 fee notice; EU Notified Body published fee lists via European Commission DG SANTE; HSA Singapore official fee schedule (revised July 2024); ANVISA published fee schedules; PMDA user fee appendix; MFDS electronic portal fee tables; NMPA registration fee schedules; CDSCO Medical Devices Rules 2017; SFDA MDMA elevation fees (updated 2025); TGA fees and charges summary (July 2025); Health Canada Fees in Respect of Drugs and Medical Devices Order (2025--2026); COFEPRIS published tariffs 2026; INVIMA registration fee estimates; Vietnam MoH Circular 64/2025 and Notification 645/TB-HTTB. Total cost estimates supplemented by Emergo by UL, Pure Global, Asia Actual, and MedDeviceGuide proprietary research.
Pure Global Published Pricing Benchmark
Pure Global is useful as a public benchmark because it publishes medical device and IVD registration pricing online while most registration providers require private quotes. The figures below are not an endorsement and do not include government, Notified Body, testing, clinical, or other third-party fees unless stated. They are a transparent starting point for budget checks; always confirm device scope, contract term, included services, and pass-through fees in writing. See Pure Global pricing.
| Market | Published service line | Public starting price | Government / authority fee note |
|---|---|---|---|
| Brazil | Brazil Registration Holder | $2,000/year for one Class I/II notification; $3,000/year for one Class III/IV registration | ANVISA notification BRL 1,405.73; registro BRL 8,509.92--19,856.48; BGMP can be BRL 72,804.90 |
| Colombia | Colombia Representative | $2,000/year for one lower-risk MD/IVD registration; $3,000/year for one higher-risk registration | INVIMA government fees range from COP 2,570,590 to COP 4,412,400 by device/IVD class |
| Mexico | Mexico Registration Holder | $2,000/year for one low-risk/Class I registration; $3,000/year for one Class II/III registration | COFEPRIS new registration fees listed from MXN 16,499 to MXN 30,798 |
| United States | U.S. Agent / Official Correspondent | $1,000/year | FDA FY2026 annual establishment registration is $11,423; standard 510(k) is $26,067 |
| European Union | EU Authorized Representative | $2,000/year for one device group; $4,000/year for five device groups | Notified Body, clinical, testing, and technical documentation costs are separate |
| Switzerland | CH-REP | $2,000/year for one registration; $4,000/year for five registrations | Swissdamed device registration fee is still TBD; custom-made device notification CHF 300 |
| United Kingdom | UK Responsible Person | $2,000/year for one registration; $4,000/year for five registrations | MHRA portal fee listed as GBP 300/year per Level 2 GMDN category from April 2026 |
| Australia | Australian Sponsor | $2,000/year for one registration; $4,000/year for five registrations | TGA application and annual ARTG fees remain separate |
| Hong Kong | Local Responsible Person | $2,000/year for one Class I/II MD or Class A/B IVD; $3,000/year for one Class III/IV MD or Class C/D IVD | MDACS currently has no government listing fee, but mandatory-regime fees may change that |
| India | Authorized Indian Agent | $2,000/year for one Class A registration; $3,000/year for one Class B/C/D registration | CDSCO fees in the partner file list Class A notification at $1,000 and Class B-D registration at $2,000--$3,000 |
| Indonesia | Local Authorized Representative | $2,000/year for one registration, all classes | Kemenkes application fees range from IDR 1,500,000 to IDR 5,000,000; importation handling may apply |
| Malaysia | Authorized Representative | $2,000/year for one Class A/B registration; $3,000/year for one Class C/D registration | MDA application and registration fees are charged separately by class |
| Singapore | Registrant | $2,000/year for one Class A/B registration; $3,000/year for one Class C/D registration | HSA application fee is SGD 560; evaluation and retention fees depend on class and route |
| Thailand | Authorized Representative | $2,000/year for one Class 1/2 registration; $3,000/year for one Class 3/4 registration | Thai FDA submission fees listed from THB 500 to THB 1,000 by class |
| Vietnam | Market Authorization Holder | $2,000/year for one registration, all classes | MoH application fees range from VND 500,000 to VND 3,000,000 in the Pure Global file |
United States (FDA)
Government Fees (FY 2026)
The FDA publishes medical device user fees annually via a Federal Register notice. For FY 2026 (October 1, 2025 through September 30, 2026), fees increased approximately 7% over FY 2025 for premarket submissions, while the annual establishment registration fee rose 23% due to a performance improvement adjustment under MDUFA V.
| Application Type | Standard Fee | Small Business Fee |
|---|---|---|
| Annual Establishment Registration | $11,423 | $11,423 (no reduction) |
| 510(k) | $26,067 | $6,517 |
| 513(g) | $7,820 | $3,910 |
| PMA, PDP, PMR, BLA | $579,272 | $144,818 |
| De Novo Classification Request | $173,782 | $43,446 |
| Panel-track Supplement | $463,418 | $115,855 |
| 180-Day Supplement | $86,891 | $21,723 |
| Real-Time Supplement | $40,549 | $10,137 |
| BLA Efficacy Supplement | $579,272 | $144,818 |
| 30-Day Notice | $9,268 | $4,634 |
| Annual Periodic Reporting (Class III) | $20,275 | $5,069 |
Source: Federal Register, "Medical Device User Fee Rates for Fiscal Year 2026," 90 FR 35895 (July 30, 2025).
Small Business Determination: A business (including affiliates) with gross receipts or sales of no more than $100 million qualifies for reduced fees. Businesses with gross receipts of $30 million or less are eligible for a one-time waiver of the first PMA/BLA fee. For FY 2026, the FDA may also waive the annual establishment registration fee for businesses with $1 million or less in gross receipts that can demonstrate financial hardship, such as active bankruptcy -- though this waiver is discretionary and rarely granted.
Total Cost Examples
510(k) Class II device: $50,000--$150,000 total, including testing, consulting, and submission preparation. The government fee ($26,067) represents roughly 17--52% of the total.
PMA Class III device: $500,000--$2M+, with clinical data requirements being the largest cost driver. The government fee ($579,272 standard) can represent 29--100% of the total depending on whether clinical trials are needed.
QMSR: ISO 13485 Now Applies to the US Market
Effective February 2, 2026, the FDA's Quality Management System Regulation (QMSR) replaced the former Quality System Regulation (21 CFR Part 820). The QMSR incorporates ISO 13485:2016 by reference, meaning that for the first time, the US quality system requirements are formally aligned with the international standard used by virtually every other major market. For manufacturers already certified to ISO 13485, this reduces the gap between US and global QMS requirements and strengthens the case for MDSAP participation.
European Union (CE Marking under MDR 2017/745)
Unlike the US, the EU has no central government fee for medical device approval. Instead, costs are driven by Notified Body assessment fees, which vary by NB, device class, and the scope of the conformity assessment.
Notified Body Fees
Notified Bodies charge hourly rates for technical file review, clinical documentation review, QMS audits, and certificate issuance. Based on published fee lists from major NBs (BSI, TUV SUD, DNV, DEKRA, SGS, and others) compiled by the European Commission DG SANTE:
Technical file review: EUR 200--430 per hour
Clinical documentation review: EUR 225--545 per hour
QMS audit: EUR 180--440 per hour per auditor (typically 2 auditors per day)
Certificate issuance: EUR 100--1,300 per certificate
Unannounced audits: EUR 2,880--8,925 per audit
For a typical Class IIa device, total NB fees range from EUR 3,000 to 10,000 for initial certification. For Class III devices, NB fees can reach EUR 15,000 or more. These are NB fees only -- they do not include the manufacturer's internal costs, consulting, or clinical evaluation preparation.
Timeline and Capacity
NB capacity constraints remain a significant issue in 2026. Current quoted review timelines are 13--18 months for initial certification, with some NBs reporting backlogs for new applications. Manufacturers should plan 6--18 months from dossier submission to CE certificate issuance, depending on device class and NB availability.
2026 Regulatory Developments
EUDAMED becomes fully mandatory on May 28, 2026, requiring actor registration, UDI/device registration, and certificate upload across four functional modules.
The European Commission's MDR/IVDR reform package (COM(2025) 1023) proposes fee reductions of at least 50% for micro-sized manufacturers and 25% for small enterprises, plus the option to defer NB fee payment until conformity assessment is finalized. These amendments are under legislative review as of early 2026.
CE certificates are valid for up to 5 years, with annual surveillance audits required.
Total Cost Range
Including NB fees, consulting, clinical evaluation, and internal resources, total costs typically range from EUR 5,000 for a simple Class I (self-certified) device to EUR 50,000+ for a Class III device requiring extensive clinical evidence.
United Kingdom (MHRA)
Since Brexit, the MHRA operates a separate registration system from the EU. Manufacturers placing devices on the Great Britain market must register with the MHRA via the Device Online Registration System (DORS).
New Annual Fee Structure (from April 2026)
Effective April 1, 2026, the MHRA replaced its one-time registration fee with an annual fee of GBP 300 per GMDN Level 2 category. This is a fundamental change in how UK registration is funded:
The fee is calculated based on the number of GMDN Level 2 categories registered as of March 31 each year.
Multiple devices under the same Level 2 category pay only one annual fee.
The MHRA estimates that 56% of manufacturers will pay only the minimum GBP 300 annual charge.
Payments are due within 90 days via DORS. Missed payments result in account suspension and loss of market access.
Manufacturers were required to verify all device registrations by March 30, 2026, and are encouraged to "cleanse" their portfolios by deregistering obsolete devices to minimize fees.
Source: The Medical Devices (Fees Amendment) Regulations 2026 (UK SI 2026/197); MHRA guidance on DORS fee implementation.
Japan (PMDA)
Japan's Pharmaceuticals and Medical Devices Agency (PMDA) operates three registration pathways based on device classification:
Registration Pathways and Costs
Todokede (Class I, low risk): Self-declaration with minimal government fees. Total project cost: $5,000--$20,000. Timeline: less than 1 month.
Ninsho (Class II, moderate risk): Third-party certification. Government fees average ~$30,000. Total project cost: $30,000--$80,000. Timeline: 3--6 months.
Shonin (Class III/IV, high risk): PMDA review. Government fees range from $20,000 to $120,000 depending on classification, clinical evidence requirements, and review complexity. Total project cost: $50,000--$200,000+. Timeline: 6--36 months.
Additional Japan-Specific Costs
DMAH/MAH (Designated Marketing Authorization Holder): Mandatory for foreign manufacturers. Annual retainer: $15,000--$50,000.
PMDA consultation meeting: ~$10,000 for a 2-hour clinical evaluation or study consultation.
QMS inspection: Required for Class II--IV devices, with 5-year renewal.
April 2026: eCTD v4.0 Mandate
Effective April 1, 2026, the PMDA mandates eCTD version 4.0 format for all new drug applications, with medical device submissions expected to follow. Companies submitting in older eCTD v3.2.2 format face rejection. This requires investment in upgraded regulatory information management systems and staff training.
South Korea (MFDS)
Government Fees
South Korea has some of the lowest government registration fees among major markets:
| Review Type | Processing Time | Government Fee |
|---|---|---|
| Class I (Notification) | 0 days | KRW 85,000 (~$73) |
| Class II with Substantial Equivalence | 25 days | KRW 130,000 (~$112) |
| Class III/IV with Substantial Equivalence | 65 days | KRW 719,000 (~$617) |
| Class II/III/IV without Substantial Equivalence | 80 days | KRW 1,495,000 (~$1,283) |
Source: MFDS electronic portal fee tables; Global Regulatory Partners fee summary (September 2022, updated for 2025--2026).
Why Total Costs Are Higher Than Fees Suggest
Despite low government fees, total project costs range from $5,000 to $60,000. The reason is KGMP certification (Korea Good Manufacturing Practices), which is mandatory for all Class II--IV devices. KGMP is specific to South Korea -- ISO 13485 certification alone is not sufficient, though the MFDS announced proposed amendments in March 2025 to allow combined KGMP/MDSAP applications, which would reduce duplication for manufacturers already in the MDSAP program.
A Korea License Holder (KLH) is also required for foreign manufacturers, adding $3,000--$10,000 per year in representative fees.
January 2026: Fast-Track for Innovative Devices
The "Market Immediate Entry Medical Technology" system, launched in late 2024, has reduced approval timelines for innovative devices (medical robots, digital therapeutics, AI diagnostics) from up to 490 days down to 80--140 days. Clinical evaluation under this pathway is flexible, accepting international clinical data, prior market experience in advanced countries, and published scientific literature.
Brazil (ANVISA)
Brazil's ANVISA operates a two-track system: notification for Class I/II devices and registration for Class III/IV devices.
Government Fees
| Pathway | Government Fee | Notes |
|---|---|---|
| Class I/II Notification | BRL 1,406 (~$265) | Per product |
| Class III/IV Registration (standard family) | BRL 8,510 (~$1,606) | Per product family |
| Class III/IV Registration (large family) | BRL 19,856 (~$3,747) | Per large product family |
| BGMP Certification | BRL 72,805 (~$13,737) | Per manufacturer, required for Class III/IV |
MDSAP Dramatically Reduces Brazil Costs
MDSAP certification is the single most impactful cost-saving measure for Brazil. Without MDSAP, manufacturers face standalone BGMP audits at BRL 72,805 plus ANVISA inspector travel costs of $10,000--$40,000. With MDSAP, the BGMP certification can be obtained through documentary review in as little as 2 months, and BGMP validity extends from 2 years to 4 years.
Add-On Costs
INMETRO certification (electrical safety): $4,000--$6,000 per device
ANATEL certification (wireless/RF): $3,000--$4,000 per device
Brazilian Registration Holder (BRH): $2,000--$5,000 setup + $1,500--$3,000/year retainer
Registration validity: 10 years
Source: ANVISA published fee schedules; MedDeviceGuide "Brazil ANVISA Medical Device Cost Breakdown 2026"; Pure Global market data.
India (CDSCO)
India offers some of the most affordable medical device registration fees globally, making it an attractive market for cost-conscious manufacturers targeting a large and growing healthcare market (~$18 billion in 2026, projected to reach $26--50 billion by 2030--2031).
Government Fees
| Device Class | Fee per Site | Fee per Device |
|---|---|---|
| Class A | $1,000 | $50 |
| Class B | $2,000 | $1,000 |
| Class C | $3,000 | $1,500 |
| Class D | $3,000 | $1,500 |
Source: CDSCO Medical Devices Rules, 2017; Artixio fee summary (February 2026).
Key Requirements
Indian Authorized Agent (IAA): Mandatory for all foreign manufacturers
BIS certification: Required for electronic medical devices
Import License: Form MD-14 application; Form MD-15 license upon approval
Validity: Perpetual, provided the license retention fee is paid every 5 years
Timeline: 5--12 months depending on device class and completeness of application
China (NMPA)
China has among the highest government registration fees for imported medical devices, reflecting the complexity of the review process and the size of the market.
Government Fees for Imported Devices
| Fee Type | Class II (Imported) | Class III (Imported) |
|---|---|---|
| Initial Registration | RMB 210,900 (~$30,000) | RMB 308,800 (~$44,000) |
| Registration Change | RMB 42,000 (~$6,000) | RMB 50,400 (~$7,200) |
| Renewal (every 5 years) | RMB 40,800 (~$5,800) | RMB 40,800 (~$5,800) |
| Clinical Trial Application | -- | RMB 43,200 (~$6,200) |
Source: NMPA fee schedules; CIRS Group fee summary; GVM Medical LLC; Asia Actual.
Key Requirements
Local agent: Mandatory for all foreign manufacturers
NMPA-certified laboratory testing: Required for Class II and III devices
Clinical data: Local clinical trials may be required, particularly for Class III devices without a "same type device" predicate
Registration validity: 5 years, with renewal required
NMPA GMP compliance audit: Revised per Announcement No. 107 of 2025, effective November 2026
2026 Regulatory Updates
The NMPA continues to issue classification catalogue adjustments, with 31 categories updated in 2025 (some down-classified, some up-classified).
Foreign-invested enterprises in China can now produce imported device registrations domestically under certain conditions (Announcement No. 30, 2025).
Saudi Arabia (SFDA)
Saudi Arabia uses a risk-based classification (Class A through D) with fees denominated in Saudi Riyals (SAR).
MDMA Registration Fees
| Device Class | SFDA Fee (SAR) | SFDA Fee (USD, approx.) | Review Period |
|---|---|---|---|
| Class A | SAR 15,000 | ~$4,000 | 35 working days |
| Class B | SAR 19,000 | ~$5,060 | 35 working days |
| Class C | SAR 21,000 | ~$5,590 | 35 working days |
| Class D | SAR 23,000 | ~$6,130 | 35 working days |
| MDMA Renewal | SAR 5,000 | ~$1,330 | -- |
| Minor Update (label/IFU) | SAR 1,100 | ~$293 | -- |
Source: SFDA MDMA Elevation Fees (official PDF, updated 2025); OMC Medical; Teriaqi.
Key Requirements
Authorized Representative (AR): Mandatory for all foreign manufacturers, with an annual AR license fee of SAR 2,600 (~$692)
GHAD System: All MDMA applications submitted electronically
Validity: 3 years
MDMA2 Saudi Route: The only valid registration pathway as of 2026 (the former GHTF/MDMA1 route was cancelled in 2021)
Australia (TGA)
Australia's TGA operates a risk-based fee structure with relatively modest application fees but potentially significant conformity assessment costs.
Application Fees (2025--2026)
| Device Class | Application Fee (AUD) | Application Fee (USD, approx.) |
|---|---|---|
| Class I | AUD 621 | ~$416 |
| Class IIa/IIb | AUD 1,187 | ~$795 |
| Class III | AUD 1,530 | ~$1,025 |
Application Audit Assessment Fees
| Audit Level | Fee (AUD) | Applies To |
|---|---|---|
| Level 1 | AUD 4,700 | Verification of conformity evidence |
| Level 2 | AUD 17,288 | In-depth technical review (Class III mandatory) |
Annual Charges
| Device Class | Annual Fee (AUD) | Annual Fee (USD, approx.) |
|---|---|---|
| Class I (other) | AUD 114 | ~$76 |
| Class I (sterile/measuring) | AUD 828 | ~$555 |
| Class IIa/IIb | AUD 1,230 | ~$824 |
| Class III/AIMD | AUD 1,566 | ~$1,049 |
Source: TGA fees and charges summary (July 2025); Asia Actual; Pure Global.
MDSAP certification can be leveraged to reduce conformity assessment costs, as TGA recognizes MDSAP audit reports as evidence of compliance.
Canada (Health Canada)
Medical Device Licence (MDL) Application Fees (2025--2026)
| Application Type | Fee (CAD) | Fee (USD, approx.) |
|---|---|---|
| Class II licence | CAD 632 | ~$465 |
| Class III licence | CAD 13,926 | ~$10,240 |
| Class III licence (near-patient IVD) | CAD 29,664 | ~$21,800 |
| Class IV licence | CAD 30,199 | ~$22,190 |
| Right to sell (annual) | CAD 452 | ~$332 |
| MDEL application/review | CAD 5,426 | ~$3,990 |
Source: Health Canada "Fees in Respect of Drugs and Medical Devices Order" (2025--2026 fee tables).
MDSAP Is Mandatory
Since January 2019, MDSAP certification has been mandatory for all Class II--IV medical devices sold in Canada. This replaced the former CMDCAS (Canadian Medical Devices Conformity Assessment System). MDSAP satisfies the QMS requirement, meaning no separate ISO 13485 audit is needed for the Canadian market.
Singapore (HSA)
Singapore's Health Sciences Authority (HSA) offers multiple evaluation routes, with fees varying significantly based on the route selected and device class.
HSA Fees (Revised July 2024)
| Registration Route | Class B (SGD) | Class C (SGD) | Class D (SGD) |
|---|---|---|---|
| Application fee | $560 | $560 | $560 |
| Immediate route | $1,000 | $3,340 | N/A |
| Expedited route | N/A | $3,340 | $5,930 |
| Abridged route | $2,010 | $3,900 | $6,250 |
| Full route | $3,900 | $6,250 | $12,000 |
Annual Retention Fees
| Device Class | Annual Fee (SGD) |
|---|---|
| Class B | $39 |
| Class C | $67 |
| Class D | $134 |
Source: HSA official fee schedule (revised July 1, 2024); Cisema; Asia Actual.
Singapore offers immediate registration for devices with reference country approvals (FDA, CE, TGA, Health Canada, PMDA), making it one of the fastest markets for devices already approved in a major jurisdiction.
Southeast Asia Overview
Vietnam
Vietnam offers the lowest government registration fees of any market covered in this guide:
| Device Class | Standard Fee | Discounted Fee (50%, through Dec 2026) | Review Time |
|---|---|---|---|
| Class A | VND 1,000,000 (~$43) | VND 500,000 (~$21) | 3--5 days |
| Class B | VND 3,000,000 (~$130) | VND 1,500,000 (~$65) | 3--5 days |
| Class C | VND 6,000,000 (~$260) | VND 3,000,000 (~$130) | 10--60 days |
| Class D | VND 6,000,000 (~$260) | VND 3,000,000 (~$130) | 10--60 days |
Source: Vietnam MoH Notification No. 645/TB-HTTB (July 2, 2025); MedDeviceGuide Vietnam registration guide.
Key points: All registration numbers are valid indefinitely under Decree 98. The 50% fee discount runs through December 31, 2026. Total project costs (including local representation, consulting, translation, and testing) range from $6,000 to $35,000.
Thailand
Thailand introduced auto-approval for Class 1 devices in February 2025, streamlining market entry for low-risk products.
Indonesia
BPOM and MoH oversee medical device regulation. Indonesia requires its own review regardless of existing CE marking or FDA clearance, meaning that prior approvals cannot be leveraged for an abbreviated pathway.
Philippines
The FDA operates under Circular 2021-002, with the ASEAN Medical Device Directive (AMDD) framework being progressively implemented. Late-renewal surcharge math (FDA Circular 2011-004) and the still-suspended AO 2024-0016 table are covered in the Philippines FDA Advisory 2026-1007 CPR renewal guide; do not treat the mixed PHP 81,000–117,000 band on the Philippines 101 as payable while DC 2026-0329 remains in force.
Malaysia
Malaysia's Medical Device Authority (MDA) joined MDSAP in September 2025, allowing manufacturers with existing MDSAP certification to use their audit reports for Malaysian market access without separate QMS inspections. Product-certificate re-registration on or after 13 July 2026 may use the Automated Re-Registration Route; Fifth Schedule application and registration fees (Class A RM 500 + RM 750 through Combination Product RM 750 + RM 5,000) and the CN-first trap are in the Malaysia MDA automated re-registration guide.
Latin America Overview
Mexico (COFEPRIS)
Government fees: MXN 15,206 (
$800) for Class I to MXN 28,394 ($1,500) for Class III30-day fast-track: Available since September 2025 for devices with FDA, Health Canada, EU MDR, Swissmedic, or TGA approval (Abbreviated Regulatory Pathway / equivalence route)
January 2026 decree: Extended registration renewal period from 5 years to up to 10 years; formalized technovigilance requirements (Article 262 Bis)
Third-party review: Available at $2,000--$4,000 in addition to government fees
Colombia (INVIMA)
Registration fees: ~$700--$1,000 government fee for controlled devices (Class IIb/III)
Total project cost: $10,000--$25,000 including representation, translation, and consulting
Validity: 10 years for medical devices (5 years for Class III IVDs)
CTD format: Required for technical submissions
Timeline: 6--8 months
Argentina (ANMAT)
Timeline: 6--12 months
IMDRF observer status
Total cost: $8,000--$20,000
Chile (ISP)
Fastest registration in the region: 3--6 months
Indefinite registration validity
Total cost: $5,000--$15,000
Peru (DIGEMID)
Timeline: 4--8 months
5-year registration renewal
Total cost: $8,000--$20,000
How to Budget for Multi-Market Registration
The 10--30% Rule
Government fees typically represent only 10--30% of the total project cost. The remaining 70--90% goes to:
Regulatory consulting and dossier preparation (25--40% of total)
Local representative or license holder fees (15--25%)
Translation and localization (5--15%)
Product testing and certification (10--20%)
Internal staff and project management (10--20%)
Clinical evidence preparation (0--40%, highly variable)
Prioritize Markets Strategically
Not all markets are equal in terms of revenue potential versus registration complexity. A practical framework:
Tier 1 (highest revenue, highest complexity): US, EU, Japan, China
Tier 2 (moderate revenue, moderate complexity): UK, Brazil, Canada, South Korea, Australia
Tier 3 (lower revenue, lower complexity): Saudi Arabia, Singapore, India, Mexico, Southeast Asia
Bundle Audits with MDSAP
The Medical Device Single Audit Program (MDSAP) is the single most cost-effective path for multi-market QMS compliance. One MDSAP audit satisfies QMS requirements for five regulatory jurisdictions simultaneously: US FDA, Health Canada, ANVISA (Brazil), PMDA/MHLW (Japan), and TGA (Australia).
According to the 2024 IMDRF Harmonization Report, MDSAP has reduced audit costs by up to 20% for participating firms. For Brazil specifically, MDSAP saves $30,000--$60,000 over 5 years by eliminating standalone BGMP audits and extending BGMP validity from 2 to 4 years.
Effective February 2, 2026, the FDA's QMSR (which incorporates ISO 13485 by reference) further strengthens the case for MDSAP, as the US quality system requirements are now formally aligned with the ISO 13485 foundation of the MDSAP audit model.
Budget for Ongoing Costs
Registration is not a one-time expense. Plan for:
Annual establishment registrations (FDA: $11,423/year)
Surveillance audits (EU NB: annual; KGMP: every 3 years)
Local representative retainers ($1,000--$10,000/year depending on market)
Annual listing fees (TGA, HSA, MHRA)
Post-market surveillance and vigilance reporting
Registration renewals (China: every 5 years; Saudi Arabia: every 3 years; Mexico: every 5--10 years)
Three-Market Budget Example
For a Class II device entering the US, EU, and one Asian market:
| Market Combination | Estimated Total Budget |
|---|---|
| US + EU + Japan | $150,000--$400,000 |
| US + EU + South Korea | $120,000--$300,000 |
| US + EU + Singapore | $100,000--$250,000 |
| US + EU + China | $130,000--$350,000 |
Key Takeaways
The range is staggering. Government fees span from $21 (Vietnam Class A, discounted) to $579,272 (FDA PMA standard). A manufacturer's total registration budget for a single device can range from under $10,000 to over $2 million depending on the market and classification.
Government fees are just the tip of the iceberg. In most markets, the government fee represents less than a quarter of the total project cost. Budget for the full ecosystem: consulting, local representation, translation, testing, and clinical evidence.
QMSR makes ISO 13485 central to US compliance. With the FDA's QMSR effective February 2026, ISO 13485 is now the foundational quality standard for both the US and global markets. This alignment reduces incremental QMS costs for multi-market manufacturers.
MDSAP is the most cost-effective multi-market strategy. One audit covers five countries. For companies targeting more than two MDSAP-recognized markets, the ROI is clear: reduced audit burden, lower per-market QMS costs, and faster market entry in Brazil and Australia where MDSAP reports are directly leveraged.
Plan 2--3 year budgets for multi-market expansion. Registration timelines range from days (Vietnam Class A, Singapore immediate route) to 36 months (Japan Shonin with clinical evidence requirements). Budget time and money accordingly, and sequence filings to optimize cash flow.
Frequently Asked Questions
Which country has the lowest medical device registration fees?
Vietnam offers the lowest government fees at approximately $21--$260 (with 50% discount through December 2026). India is also very affordable at $1,000--$3,000 per site. However, remember that government fees represent only a fraction of total project costs -- local representation, translation, and consulting can multiply the total by 5--20x.
Which country has the highest medical device registration fees?
The US FDA has the highest fees by far: $579,272 for a standard PMA submission and $26,067 for a 510(k). Japan's PMDA can also exceed $120,000 in government fees for Shonin (Class III/IV) applications that require clinical evidence consultation and extended review.
Does MDSAP reduce registration costs?
Yes, significantly. For Brazil alone, MDSAP saves $30,000--$60,000 over 5 years by eliminating standalone BGMP audits and extending BGMP certificate validity. For multi-market manufacturers, MDSAP replaces 5 separate QMS audits (US, Canada, Brazil, Japan, Australia) with a single audit cycle, reducing both direct audit fees and internal preparation costs. The 2024 IMDRF Harmonization Report estimates up to 20% cost savings for participating firms.
How much should I budget for 3-market registration?
For a Class II device entering the US, EU, and one Asian market: budget $80,000--$250,000 total depending on the Asian market chosen. Japan and China are the most expensive ($150,000--$400,000 combined). Singapore and South Korea are more moderate ($100,000--$300,000 combined). These estimates include government fees, consulting, local representation, translation, and testing.
Are small business fee reductions available?
The US FDA offers the most significant small business reductions: 510(k) drops from $26,067 to $6,517 (75% reduction), and PMA from $579,272 to $144,818 (75% reduction). Qualification requires gross receipts/sales of $100 million or less including affiliates. Businesses with $30 million or less in gross receipts also qualify for a one-time first PMA/BLA fee waiver. For FY 2026, businesses with $1 million or less in gross receipts may qualify for an annual registration fee waiver if they can demonstrate financial hardship. Other markets (EU NB reform proposals, Health Canada small business reductions) offer more modest fee relief.